141 related articles for article (PubMed ID: 11142830)
21. [Vertical trasmission of human immunodeficiency virus (HIV) and other sexually transmitted infections (STI)].
Casalini C; Signorini L; Beltrame A; Matteelli A; Carosi G
Minerva Ginecol; 2001 Jun; 53(3):177-92. PubMed ID: 11395690
[TBL] [Abstract][Full Text] [Related]
22. Morbidity that is associated with curettage for the management of spontaneous and induced abortion in women who are infected with HIV.
Stuart GS; Sheffield JS; Hill JB; McIntire DD; McElwee B; Wendel GD
Am J Obstet Gynecol; 2004 Sep; 191(3):993-7. PubMed ID: 15467578
[TBL] [Abstract][Full Text] [Related]
23. [Management of HIV seropositive pregnant women and HIV seronegative women with seropositive partners].
Blanc B; Boubli L; Cohen M
Rev Prat; 1990 Jan; 40(2):127-30. PubMed ID: 2300769
[TBL] [Abstract][Full Text] [Related]
24. Hospitalizations of pregnant HIV-infected women in the USA prior to and during the era of HAART, 1994-2003.
Kourtis AP; Bansil P; McPheeters M; Meikle SF; Posner SF; Jamieson DJ
AIDS; 2006 Sep; 20(14):1823-31. PubMed ID: 16954723
[TBL] [Abstract][Full Text] [Related]
25. Effect of antiretroviral agents on carbohydrate metabolism in HIV-1 infected pregnant women.
El Beitune P; Duarte G; Foss MC; Montenegro RM; Spara P; Quintana SM; Figueiró-Filho EA; da Costa AG; Filho FM
Diabetes Metab Res Rev; 2006; 22(1):59-63. PubMed ID: 16021650
[TBL] [Abstract][Full Text] [Related]
26. Drug resistance among HIV-infected pregnant women receiving antiretrovirals for prophylaxis.
Duran AS; Losso MH; Salomón H; Harris DR; Pampuro S; Soto-Ramirez LE; Duarte G; de Souza RS; Read JS;
AIDS; 2007 Jan; 21(2):199-205. PubMed ID: 17197811
[TBL] [Abstract][Full Text] [Related]
27. Incidence and consequences of pregnancy in women with known duration of HIV infection. Italian Seroconversion Study Group.
Alliegro MB; Dorrucci M; Phillips AN; Pezzotti P; Boros S; Zaccarelli M; Pristerà R; Rezza G
Arch Intern Med; 1997 Dec 8-22; 157(22):2585-90. PubMed ID: 9531227
[TBL] [Abstract][Full Text] [Related]
28. Trends in pregnancy rates among women with human immunodeficiency virus.
Blair JM; Hanson DL; Jones JL; Dworkin MS
Obstet Gynecol; 2004 Apr; 103(4):663-8. PubMed ID: 15051556
[TBL] [Abstract][Full Text] [Related]
29. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
Palombi L; Marazzi MC; Voetberg A; Magid NA
AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
[TBL] [Abstract][Full Text] [Related]
30. [Highly active antiretroviral therapy (HAART) in HIV-positive pregnant women in the Netherlands, 1997-2003: safe, effective and with few side effects].
Tempelman C; Timmermans S; Godfried MH; Dieleman JP; Boer K; van der Ende ME
Ned Tijdschr Geneeskd; 2004 Oct; 148(41):2021-5. PubMed ID: 15553999
[TBL] [Abstract][Full Text] [Related]
31. Herpes simplex virus type 2 and risk of intrapartum human immunodeficiency virus transmission.
Drake AL; John-Stewart GC; Wald A; Mbori-Ngacha DA; Bosire R; Wamalwa DC; Lohman-Payne BL; Ashley-Morrow R; Corey L; Farquhar C
Obstet Gynecol; 2007 Feb; 109(2 Pt 1):403-9. PubMed ID: 17267842
[TBL] [Abstract][Full Text] [Related]
32. [Refusal of prenatal HIV-testing: a case study in Abidjan (Côte d'Ivoire)].
Desgrées du Loû A; Brou H; Djohan G; Tijou-Traoré A;
Sante; 2007; 17(3):133-41. PubMed ID: 18180214
[TBL] [Abstract][Full Text] [Related]
33. HIV-infected pregnant women and vertical transmission in Europe since 1986. European collaborative study.
AIDS; 2001 Apr; 15(6):761-70. PubMed ID: 11371691
[TBL] [Abstract][Full Text] [Related]
34. The relationship of pregnancy to the use of highly active antiretroviral therapy.
Minkoff H; Ahdieh L; Watts H; Greenblatt RM; Schmidt J; Schneider M; Stek A
Am J Obstet Gynecol; 2001 May; 184(6):1221-7. PubMed ID: 11349192
[TBL] [Abstract][Full Text] [Related]
35. HIV RNA viral load and CD4+ T-cell counts in HIV-infected pregnant women with and without treatment discontinuation in early pregnancy.
Tamburrini E; Ravizza M; Floridia M; Tibaldi C; Alberico S; Anzidei G; Maccabruni A; Meloni A; Antoni AD; Mori F; Dalzero S; Conservan V; Pinnetti C; Ferrazzi E;
Antivir Ther; 2008; 13(4):519-27. PubMed ID: 18672530
[TBL] [Abstract][Full Text] [Related]
36. Vertical HIV-1 transmission: prophylaxis and paediatric follow-up.
Carneiro M; Sanchéz A; Maneiro P; Angelosante W; Pérez C; Valleé M
Placenta; 2001 Apr; 22 Suppl A():S13-8. PubMed ID: 11312622
[TBL] [Abstract][Full Text] [Related]
37. Pregnancy outcome among HIV-infected women in the Helsinki metropolitan area.
Lehtovirta P; Skogberg K; Salo E; Ammälä P; Ristola M; Suni J; Paavonen J; Heikinheimo O
Acta Obstet Gynecol Scand; 2005 Oct; 84(10):945-50. PubMed ID: 16167909
[TBL] [Abstract][Full Text] [Related]
38. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
[TBL] [Abstract][Full Text] [Related]
39. Obstetric and newborn infant outcomes in human immunodeficiency virus-infected women who receive highly active antiretroviral therapy.
Haeri S; Shauer M; Dale M; Leslie J; Baker AM; Saddlemire S; Boggess K
Am J Obstet Gynecol; 2009 Sep; 201(3):315.e1-5. PubMed ID: 19733286
[TBL] [Abstract][Full Text] [Related]
40. Cervical dyskaryosis among women with and without HIV: prevalence and risk factors.
Mbizvo EM; Msuya SE; Stray-Pedersen B; Chirenje MZ; Hussain A
Int J STD AIDS; 2005 Dec; 16(12):789-93. PubMed ID: 16336759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
